1. Home
  2. STAA vs ANIP Comparison

STAA vs ANIP Comparison

Compare STAA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$24.81

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$81.17

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAA
ANIP
Founded
1982
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STAA
ANIP
Price
$24.81
$81.17
Analyst Decision
Hold
Strong Buy
Analyst Count
10
7
Target Price
$24.56
$102.14
AVG Volume (30 Days)
1.2M
417.1K
Earning Date
11-05-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.67
Revenue
$230,591,000.00
$826,880,000.00
Revenue This Year
N/A
$43.41
Revenue Next Year
$22.61
$9.66
P/E Ratio
N/A
$48.00
Revenue Growth
N/A
48.87
52 Week Low
$13.50
$52.50
52 Week High
$30.81
$99.50

Technical Indicators

Market Signals
Indicator
STAA
ANIP
Relative Strength Index (RSI) 46.81 40.01
Support Level $23.03 $79.98
Resistance Level $25.35 $83.00
Average True Range (ATR) 1.10 2.17
MACD -0.17 0.21
Stochastic Oscillator 40.44 24.35

Price Performance

Historical Comparison
STAA
ANIP

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: